Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.61 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20763051 | 0.84 | TGM2 (0.58) | TGM2SMN1; SMN2KMT2AMEN1LMNA | |
| SCHEMBL732934 | 0.84 | TGM2 (0.81) | TGM2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL12230798 | 0.84 | TGM2 (0.54) | TGM2SMN1; SMN2KMT2AMEN1HPGD | |
| SCHEMBL4743993 | 0.82 | TGM2 (0.63) | TGM2SMN1; SMN2KMT2AMEN1HPGD | |
| SCHEMBL890926 | 0.81 | TGM2 (0.67) | TGM2KMT2AMEN1ALDH1A1 | |
| SCHEMBL5357067 | 0.80 | KMT2A (0.68) | LOXL2CA1CA2SMN1; SMN2KMT2A | |
| SCHEMBL959540 | 0.80 | TGM2 (0.69) | TGM2SMN1; SMN2KMT2AMEN1HPGD | |
| SCHEMBL23316960 | 0.78 | LOXL2 (0.58) | LOXL2CA1CA2SMN1; SMN2KMT2A | |
| SCHEMBL13920455 | 0.78 | LOXL2 (0.58) | LOXL2CA1CA2SMN1; SMN2KMT2A | |
| SCHEMBL22253411 | 0.78 | LOXL2 (0.62) | LOXL2CA1CA2SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2572243-B1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORP (JP) | 2021-04-07 | — | — | EP | disclosed |
| EP-3414230-B1 | TETRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | C26 BIOSCIENCE AB (SE) | 2020-05-06 | — | — | EP | disclosed |
| US-10577333-B2 | Tetrazole derivatives as cytochrome P450 inhibitors | C26 BIOSCIENCE AB (SE) | 2020-03-03 | — | — | US | disclosed |
| US-20190293641-A1 | ASSAY | IMPERIAL COLLEGE INNOVATIONS, LTD. (GB) | 2019-09-26 | — | — | US | disclosed |
| EP-2568339-B1 | Lithographic printing plate precursor and method of manufacturing lithographic printing plate | FUJIFILM CORP (JP) | 2019-05-08 | — | — | EP | disclosed |
| EP-2598946-B1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORP (JP) | 2019-04-03 | — | — | EP | disclosed |
| US-20190040020-A1 | TETRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | C26 BIOSCIENCE AB (SE) | 2019-02-07 | — | — | US | disclosed |
| US-20180321586-A1 | PLANOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE, AND ORGANIC-INORGANIC HYBRID PARTICLE | FUJIFILM CORPORATION (JP) | 2018-11-08 | — | — | US | disclosed |
| EP-2555054-B1 | METHOD FOR MANUFACTURING A LITHOGRAPHIC PRINTING PLATE AND PRINTING METHOD | FUJIFILM CORP (JP) | 2018-06-20 | — | — | EP | disclosed |
| EP-3330096-A1 | PLANOGRAPHIC PRINTING PLATE ORIGINAL, PLANOGRAPHIC PRINTING PLATE MANUFACTURING METHOD, AND ORGANIC-INORGANIC HYBRID PARTICLES | FUJIFILM Corporation (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20120068292-A1 | POLYMERIZABLE COMPOSITION, AND PHOTOSENSITIVE LAYER, PERMANENT PATTERN, WAFER-LEVEL LENS, SOLID-STATE IMAGING DEVICE AND PATTERN FORMING METHOD EACH USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| WO-2012015076-A1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-02-02 | — | — | WO | disclosed |
| WO-2011145742-A1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-11-24 | — | — | WO | disclosed |
| EP-2378361-A1 | Method for preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| EP-2367056-A2 | Method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-2354851-A2 | Lithographic printing plate precursor and method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-20110159437-A1 | METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-2339405-A1 | Method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-06-29 | — | — | EP | disclosed |
| EP-2339401-A1 | Method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-06-29 | — | — | EP | disclosed |
| EP-2339402-A1 | Lithographic printing plate precursor and method of preparing lithographic printing plate | Fujifilm Corporation (JP) | 2011-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040020-A1 | TETRAZOLE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | CYP1A2, CYP2E1, CYP1A1 | TGM2 721/4885LOXL2 1762/4885CA1 3700/4885 |
| US-10577333-B2 | Tetrazole derivatives as cytochrome P450 inhibitors | CYP1A2, CYP2E1, CYP1A1 | TGM2 721/4885LOXL2 1762/4885CA1 3700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.